Literature DB >> 29759086

Comprehensive nationwide analysis of mother-to-child HIV transmission in Finland from 1983 to 2013.

I Aho1, P Kivelä1, M Kaijomaa2, H-M Surcel3, M Ristola1, O Heikinheimo2, J Sutinen1.   

Abstract

HIV-positive children are still born in Europe despite low mother-to-child transmission (MTCT) rates. We aimed to clarify the remaining barriers to the prevention of MTCT. By combining the national registers, we identified all women living with HIV delivering at least one child during 1983-2013. Of the 212 women delivering after HIV diagnosis, 46% were diagnosed during the pregnancy. In multivariate analysis, age >30 years (P = 0.001), sexual transmission (P = 0.012), living outside of the metropolitan area (P = 0.001) and Eastern European origin (P = 0.043) were risk factors for missed diagnosis before pregnancy. The proportion of immigrants increased from 18% before 1999 to 75% during 2011-2013 (P < 0.001). They were diagnosed during the pregnancy equally to natives and achieved similar, good treatment results. No MTCT occurred when the mother was diagnosed before the delivery. In addition, 12 women had delivered in 2 years prior their HIV diagnosis, most before implementation of the national screening of pregnant women. Three of these children were infected, the last one in 2000. Our data demonstrate that complete elimination of MTCT is feasible in a high-income, low-prevalence country. This requires ongoing universal screening in early pregnancy and easy access to antiretroviral therapy to all HIV-positive people.

Entities:  

Keywords:  Epidemiology; HIV/AIDS; prevention

Mesh:

Substances:

Year:  2018        PMID: 29759086      PMCID: PMC9134292          DOI: 10.1017/S0950268818001280

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  15 in total

1.  Determinants of late HIV diagnosis among different transmission groups in Finland from 1985 to 2005.

Authors:  P S Kivelä; A Krol; M O Salminen; M A Ristola
Journal:  HIV Med       Date:  2009-12-08       Impact factor: 3.180

2.  Migrant women living with HIV in Europe: are they facing inequalities in the prevention of mother-to-child-transmission of HIV?: The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.

Authors:  G Favarato; H Bailey; F Burns; L Prieto; A Soriano-Arandes; C Thorne
Journal:  Eur J Public Health       Date:  2018-02-01       Impact factor: 3.367

3.  Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.

Authors:  A Reitter; A U Stücker; R Linde; C Königs; G Knecht; E Herrmann; R Schlößer; F Louwen; A Haberl
Journal:  HIV Med       Date:  2014-03-06       Impact factor: 3.180

4.  Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008.

Authors:  M L von Linstow; V Rosenfeldt; A M Lebech; M Storgaard; T Hornstrup; T L Katzenstein; G Pedersen; T Herlin; N H Valerius; N Weis
Journal:  HIV Med       Date:  2010-02-08       Impact factor: 3.180

5.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

6.  Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Authors:  Claire L Townsend; Laura Byrne; Mario Cortina-Borja; Claire Thorne; Annemiek de Ruiter; Hermione Lyall; Graham P Taylor; Catherine S Peckham; Pat A Tookey
Journal:  AIDS       Date:  2014-04-24       Impact factor: 4.177

7.  Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Authors:  Josiane Warszawski; Roland Tubiana; Jerome Le Chenadec; Stephane Blanche; Jean-Paul Teglas; Catherine Dollfus; Albert Faye; Marianne Burgard; Christine Rouzioux; Laurent Mandelbrot
Journal:  AIDS       Date:  2008-01-11       Impact factor: 4.177

8.  Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence.

Authors:  Jesús Castilla; Paz Sobrino; Luis De La Fuente; Isabel Noguer; Luis Guerra; Francisco Parras
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

9.  High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort.

Authors:  Sarah M Gerver; Tim R Chadborn; Fowzia Ibrahim; Bela Vatsa; Valerie C Delpech; Philippa J Easterbrook
Journal:  J Int AIDS Soc       Date:  2010-08-04       Impact factor: 5.396

10.  Adequacy of prenatal care among women living with human immunodeficiency virus: a population-based study.

Authors:  Ryan Ng; Erin M Macdonald; Mona R Loutfy; Mark H Yudin; Janet Raboud; Khatundi-Irene Masinde; Ahmed M Bayoumi; Wangari E Tharao; Jason Brophy; Richard H Glazier; Tony Antoniou
Journal:  BMC Public Health       Date:  2015-05-29       Impact factor: 3.295

View more
  3 in total

1.  Study protocol: becoming and being a mother living with HIV - a multicentre longitudinal mixed methods study among pregnant women living with HIV, non-pregnant women living with HIV and pregnant women not living with HIV in a high-income setting (the 2B MOM study).

Authors:  Ellen Moseholm; Micheal D Fetters; Inka Aho; Åsa Mellgren; Isik S Johansen; Merete Storgaard; Gitte Pedersen; Terese L Katzenstein; Nina Weis
Journal:  BMJ Open       Date:  2019-10-15       Impact factor: 2.692

2.  The experience of pregnancy among women living with HIV in Nordic countries: A qualitative narrative enquiry.

Authors:  Ellen Moseholm; Inka Aho; Åsa Mellgren; Isik S Johansen; Merete Storgaard; Gitte Pedersen; Ditte Scofield; Terese L Katzenstein; Nina Weis
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

3.  Finnish HIV Quality of Care Register (FINHIV).

Authors:  Mikaela Mutru; Sanna Isosomppi; Inka Aho; Kirsi Liitsola; Henrikki Brummer-Korvenkontio; Jukka Ollgren; Oskari Luomala; Pia Kivelä
Journal:  BMJ Open       Date:  2022-01-21       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.